Quantifying Disease Risk Using Genomics: the New Paradigm

Peter Donnelly is a professor of statistical science at the University of Oxford and the CEO of Genomics PLC, which uses large-scale human genetic data to inform healthcare and drug discovery. In this interview he, Lauren Richardson, and a16z general partner Vineeta Agarwala discuss the concept of polygenic risk scores with and how this lets... Read More The post Quantifying Disease Risk Using Genomics: the New Paradigm appeared first on Future....

Submit